📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
43%
🔄 Reverse Split
65%
• 50-day avg $0.78 below $1 exchange minimum
• 10 months cash with weak price
📉 Score Deterioration
25%
• Score increased 14 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (10mo)
💹 Market Data
Market Cap$27.25M
Shares Outstanding35.14M
Float22.96M
Cash$17.11M
Debt$311.3K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 21.2% shares (2025Q4 vs prior)
51 institutional holders · 16.21M shares
#1
5AM Venture Management, LLC
9.68M shares
#2
Versant Venture Management, LLC
2.01M shares
#3
BAKER BROS. ADVISORS LP
1.45M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.27M
Days to Cover7.2
% of Float5.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SKYE
📊 SKYE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SKYE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.